Phase I trial of KUX 1151 in Japan for the treatment of gout and hyperuricaemia
Latest Information Update: 30 Dec 2013
At a glance
- Drugs KUX 1151 (Primary)
- Indications Gout; Hyperuricaemia
- Focus Adverse reactions
- Sponsors Kissei Pharmaceutical
- 30 Dec 2013 New trial record